Acadia Pharmaceuticals (ACAD) PT Raised to $54 at Jefferies
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $29.58 --0%
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 7
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 7
Join SI Premium – FREE
Jefferies analyst Chris Howerton raised the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $54.00 (from $53.00) while maintaining a Buy rating.
You May Also Be Interested In
- Acadia Pharmaceuticals (ACAD) PT Raised to $28 at Morgan Stanley
- Kepler Cheuvreux Upgrades United Internet (UTDI:GR) (UDIRY) to Buy
- Okta, Inc (OKTA) PT Raised to $187 at BMO Capital, Stays Top Pick
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
